Clinical ink announces EDCXtra™ : An integrated web-based EDC, DDC and eCOA platform
Clinical ink announces EDCXtra: An integrated web-based EDC, DDC and eCOA platform.
Press Release
Clinical ink Appoints Dr. Nicholas Alp, MD PhD as Chief Medical Officer
Clinical ink announced the appointment of Dr. Nicholas Alp as Chief Medical Officer will lead the creation of innovative solutions and commercial strategies for clinical trial technology based on his experience as an interventional cardiologist and clinical trialist.
Clinical ink announces GlucoseReady™
Clinical ink announces an integrated suite of eClinical tools for cardiometabolic clinical trials.
Clinical ink Expands Patient Engagement Solutions with Behavioral Diagnostic Tool SPUR™
Clinical ink is expanding its patient engagement suite with the inclusion of the SPUR™ behavioral diagnostic tool created by Observia.
Clinical ink Introduces Breakthrough Solution to Drastically Reduce Study Build Timelines
Clinical ink is setting a new industry benchmark in advancing study build timelines. Harnessing the power of the latest eCOA technology, Clinical ink can now reduce study build timelines to as little as 10 days.
Clinical ink Enhances Data Management Services, and Announces Senior Hires in Data Management and Data Integrity
Clinical ink, a global life science technology company, announces the appointment of Jeff Bock, Vice President of Data Management and Tom Haag, Vice President of Data Quality Control.
Clinical ink Appoints Andrew Kraus as Chief Technology Officer
Clinical ink announced the appointment of Andrew Kraus as Chief Technology Officer who will lead the development of the company’s expanding technology portfolio to support clinical trials.
Clinical ink and Teckro Partner to Enhance Site User Engagement
Clinical ink is delighted to announce its partnership with Teckro, a trailblazer in site user engagement and clinical trial technology solutions.
Clinical ink Work Demonstrating Technology Sensitivity to Parkinson’s Disease Published in Nature
Clinical ink announces the publication of “Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study” in npj Parkinson’s Disease.
Clinical ink Announces New Continuous Glucose Monitoring Solution
Clinical ink now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution.
Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
Clinical ink announces its strategic partnership with Mural Health, a next-generation participant management platform.
Clinical ink Forms Strategic Alliance with Boston Clinical Research Institute
Clinical ink, a global life science technology company, announces a strategic alliance with The Boston Clinical Research Institute (BCRI), an Academic Research Organization (ARO) based in Boston, Massachusetts. The alliance will combine BCRI’s leadership in clinical strategy, therapeutic area expertise, and academic collaboration with Clinical ink’s expertise in eSource technology.
